Chlorothiazide Sodium
Chlorothiazide Sodium for Injection, USP
Approved
Approval ID
5046a4d7-7742-4f19-930a-2582cb41474e
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Aug 29, 2022
Manufacturers
FDA
Akorn
DUNS: 117693100
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Chlorothiazide Sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code17478-419
Application NumberNDA011145
Product Classification
M
Marketing Category
C73605
G
Generic Name
Chlorothiazide Sodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateAugust 10, 2012
FDA Product Classification
INGREDIENTS (3)
Sodium HydroxideInactive
Code: 55X04QC32I
Classification: IACT
MannitolInactive
Quantity: 250 mg in 1 1
Code: 3OWL53L36A
Classification: IACT
Chlorothiazide SodiumActive
Quantity: 500 mg in 1 1
Code: SN86FG7N2K
Classification: ACTIM